The company's fundamentals are relatively healthy.Its valuation is considered fairly valued,and institutional recognition is very high.Over the past 30 days, multiple analysts have rated the company as a Buy.Despite a weak stock market performance, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Industry at a Glance
Industry Ranking
6 / 280
Overall Ranking
67 / 4751
Industry
Healthcare Services & Equipment
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analysts' Target
Based on
9
analysts
Buy
Current Rating
272.488
Target Price
+11.32%
Upside Space
Disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.35% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 474.27.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 36.04%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 36.04%.
Undervalued
The company’s latest PE is 37.31, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 92.92M shares, decreasing 2.55% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 12.12M shares of this stock.
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.